AIとがん研究 ── 肝臓がん ── 2026-11-16
肝臓がん 2 本。筆頭: Pretreatment CT-based 3D deep learning feature model for predicting treatment response and stratifying survival after immunotherapy rechallenge in hepatocellular carcinoma
肝臓がんの治療・治験とAI
- Pretreatment CT-based 3D deep learning feature model for predicting treatment response and stratifying survival after immunotherapy rechallenge in hepatocellular carcinoma抄録(全訳)掲載誌の IF 相当:7.6(OpenAlex の直近 2 年の平均被引用数・2026-11-04 時点の値、2026-11-05 に取得。正式な IF(Clarivate)ではない)書誌:Li Z, Lu Z, Ye C, Huang R, Zhang L. Pretreatment CT-based 3D deep learning feature model for predicting treatment response and stratifying survival after immunotherapy rechallenge in hepatocellular carcinoma. BMC Med Inform Decis Mak. 2026 Nov 14 [Epub ahead of print]. doi:10.1186/s12911-026-03978-0.確認の範囲:抄録のみ確認
- Peri-ablational contrast-enhanced CT radiomics for predicting early progression of hepatocellular carcinoma after microwave ablation: development and external validation of a clinical-radiomics model.抄録(全訳)掲載誌の IF 相当:3.1(OpenAlex の直近 2 年の平均被引用数・2026-11-12 時点の値、2026-11-13 に取得。正式な IF(Clarivate)ではない)書誌:Fu Y, Jiao L, Yu P, Meng Z, Qiu S, Wang Y, et al. Peri-ablational contrast-enhanced CT radiomics for predicting early progression of hepatocellular carcinoma after microwave ablation: development and external validation of a clinical–radiomics model. Abdom Radiol (NY). 2026 Nov 12 [Epub ahead of print]. doi:10.1007/s00261-026-05863-w. PMID: 43018705.確認の範囲:抄録のみ確認